Alphaa-crystallin mimetic peptides and uses thereof
Abstract:
This invention relates to αA-crystallin protein modulating compounds (e.g., phosphomimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment and prevention of conditions involving neurodegeneration and neuroinflammation.
Public/Granted literature
Information query
Patent Agency Ranking
0/0